Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 5/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.35 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.32 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.32 |
| ▸ | GMNN | O75496 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | THPO | P40225 | 1/20 | 0.32 |
| ▸ | MTOR | P42345 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29629358 | 1.00 | TSHR (0.50) | TSHRLMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL542040 | 1.00 | TSHR (0.50) | TSHRLMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL812000 | 1.00 | TSHR (0.50) | TSHRLMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL152197 | 1.00 | TSHR (0.50) | TSHRLMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL7318317 | 1.00 | TSHR (0.50) | TSHRLMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL5712959 | 1.00 | TSHR (0.50) | TSHRLMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL21410063 | 1.00 | TSHR (0.50) | TSHRLMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL22749286 | 1.00 | TSHR (0.50) | TSHRLMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL21410057 | 1.00 | TSHR (0.50) | TSHRLMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL9742577 | 1.00 | TSHR (0.50) | TSHRLMNAALDH1A1HSD17B10MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 145 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113385212-B | Non-metal doped carbon-based catalyst for preparing enol and method for preparing enol by using same | 上海巽田科技股份有限公司 | 2022-12-27 | — | — | CN | claimed |
| CN-113385212-A | Non-metal doped carbon-based catalyst for preparing enol and method for preparing enol by using same | 青岛化赫医药科技有限公司 | 2021-09-14 | — | — | CN | claimed |
| EP-1448177-A1 | AMINO DIOLS USEFUL IN THE TREATMENT OF ALZHEIMER'S DISEASE | Elan Pharmaceuticals, Inc. (US) | 2004-08-25 | — | — | EP | claimed |
| WO-2003043618-A2 | AMINO DIOLS USEFUL IN THE TREATMENT OF ALZHEIMER'S DISEASE | ELAN PHARMACEUTICALS, INC. (US) | 2003-05-30 | — | — | WO | claimed |
| US-5487898-A | PEPTIDES | ABBOTT LABORATORIES (US) | 1996-01-30 | — | — | US | claimed |
| EP-0569487-A4 | — | — | 1994-04-27 | — | — | EP | claimed |
| EP-0569487-A1 | ENDOTHELIN CONVERTING ENZYME INHIBITORS | ABBOTT LABORATORIES (US) | 1993-11-18 | — | — | EP | claimed |
| EP-0444156-A4 | METHOD FOR TREATING VASCULAR DISEASES | — | 1992-12-09 | — | — | EP | claimed |
| EP-0439556-A4 | HETEROCYCLIC PEPTIDE RENIN INHIBITORS | — | 1991-10-30 | — | — | EP | claimed |
| EP-0444156-A1 | METHOD FOR TREATING VASCULAR DISEASES | ABBOTT LABORATORIES (US) | 1991-09-04 | — | — | EP | claimed |
| US-20260132350-A1 | FLUID DYNAMIC BEARING, SPINDLE MOTOR, AND DISK DRIVE DEVICE | MINEBEA MITSUMI INC (JP) | 2026-05-14 | — | — | US | disclosed |
| CN-116157449-B | Rubber particle, composite particle, and method for producing same | 信越化学工业株式会社 | 2025-06-10 | — | — | CN | disclosed |
| CN-120035636-A | Composite resin, aqueous resin dispersion, coating composition, and aqueous coating material | 三菱化学株式会社 | 2025-05-23 | — | — | CN | disclosed |
| CN-118995035-B | Coating composition, UV light conversion coating, preparation method of UV light conversion coating, photovoltaic cell and photovoltaic module | 上海德朗聚新材料有限公司 | 2025-04-22 | — | — | CN | disclosed |
| US-12252620-B2 | Ink jet ink composition, ink set, and ink jet recording method | SEIKO EPSON CORPORATION (JP) | 2025-03-18 | — | — | US | disclosed |
| WO-1990003389-A1 | RENIN INHIBITORY PEPTIDES CONTAINING MALEAMIDE SUBSTITUENTS | THE UPJOHN COMPANY (US) | 1990-04-05 | — | — | WO | disclosed |
| WO-1990002137-A1 | RENIN INHIBITORY PEPTIDES CONTAINING SULEPTANIC ACID OR DERIVATIVES THEREOF | THE UPJOHN COMPANY (US) | 1990-03-08 | — | — | WO | disclosed |
| WO-1990000050-A1 | AMINOALKYLAMINOCARBONYL AMINODIOL AMINO ACID DERIVATIVES AS ANTI-HYPERTENSIVE AGENTS | G.D. SEARLE & CO. (US) | 1990-01-11 | — | — | WO | disclosed |
| EP-0295294-A1 | PEPTIDYLAMINODIOLS | ABBOTT LABORATORIES (US) | 1988-12-21 | — | — | EP | disclosed |
| WO-1988005050-A1 | PEPTIDYLAMINODIOLS | ABBOTT LABORATORIES (US) | 1988-07-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260132350-A1 | FLUID DYNAMIC BEARING, SPINDLE MOTOR, AND DISK DRIVE DEVICE | KIF15, KIF5B, DYNLL1 | TSHR 1695/4885LMNA 2732/4885ALDH1A1 4532/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.